Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-07

Clinical Trial Update: Desmopressin for Bedwetting in Children With SCD [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating desmopressin for bedwetting in children with sickle cell disease was terminated, with results posted in May 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desmopressin (Desmopressin)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Nocturnal Enuresis, Anemia, Sickle Cell | Phase 4 | Status: TERMINATED | Results posted: 2024-05-07